Kisspeptin: A new drug to treat liver disease?
A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new research......»»
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
FDA is reviewing its decision to remove tirzepatide drugs from the shortage list. Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take.....»»
Bacteria discovered in healthy vertebrate brains point to a potential role in brain function
Researchers at the University of New Mexico have identified the presence of bacteria in the healthy brains of fish. Understanding this connection between bacteria and animal brains could have future implications for the study of Alzheimer's disease......»»
New salicylic acid-based strategy could balance disease resistance with plant growth
Researchers at the University of Georgia have identified a promising approach to addressing a longstanding challenge for plant geneticists: balancing disease resistance and growth in plants......»»
Calcium transport protein in bacteria offers insights for drug development and food safety
Researchers at Umeå University have revealed details on how bacteria use calcium to regulate vital processes in a way that differs from human cells. This breakthrough is significant in the fight against antibiotic resistance and for increasing safet.....»»
Quantum research unlocks PET scan potential in disease detection
New research in quantum entanglement could vastly improve disease detection, such as for cancer and Alzheimer's disease......»»
I was a beta tester for the Nobel prize-winning AlphaFold AI—it"s going to revolutionize health research
The deep learning machine AlphaFold, which was created by Google's AI research lab DeepMind, is already transforming our understanding of the molecular biology that underpins health and disease......»»
Why a diabetes drug fell short of anticancer hopes
Studies suggested it could treat cancer, but the clinical trials were a bust. Pamela Goodwin has received hundreds of emails from patients asking if they should take a cheap, read.....»»
Analysis of approximately 75 million publications finds those employing AI are more likely to be a "hit paper"
From designing new drug candidates in medicine to drafting new taxation policies in social sciences, the benefits of artificial intelligence (AI) in scientific research are all around......»»
Study unveils cobalt(III) reaction mechanism with nitriles, opening pathways for drug development
A research team led by Professor Jaeheung Cho from the Department of Chemistry at UNIST has published a study in the Journal of the American Chemical Society reporting the reaction mechanism of cobalt(III)-based metal complexes with nitrile substance.....»»
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the arteries. Advanced treatments.....»»
Genetic mechanism unlocks a key secret behind disease infection in crops
Researchers have unraveled a key genetic mechanism behind the way pathogens infect crops, leading to new strategies for breeding resistant crop varieties against other pathogens carrying the same genetic mechanism......»»
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
Compounding pharmacies could make knockoffs during shortage. But FDA says it's over. Compounding pharmacies are suing the Food and Drug Administration so they can keep making imit.....»»
Making micelles more effective for dye and drug dispersion through well-defined core-shell structures
Micelles are spherical molecular structures usually formed by amphiphilic molecules with block structure, which contain both hydrophilic and hydrophobic parts. The hydrophobic tails of these molecules cluster together to form a core, while the hydrop.....»»
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation......»»
Study reveals how parasites thrive by balancing specialization with exploiting diverse species communities
A single shift of a parasite from one host species to another can trigger catastrophic infectious disease outbreaks. Despite this, scientists continue to debate the role of species diversity in natural environments on the spread of these parasites......»»
Researchers design a drug capable of acting simultaneously against three different therapeutic targets
A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different thera.....»»
Research team develops metallodrug-antibiotic combination strategy to combat superbugs
Antimicrobial resistance (AMR) bacterial infections have become a serious problem threatening human health worldwide. The overuse of antibiotics has promoted drug-resistant mutations in bacteria, causing almost all clinically used antibiotics to deve.....»»
Artificial proteasome offers insights for new trichomoniasis treatments
Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants. In one current study, they have focused on the disease caused by the protozoan parasite Trichomonas vagina.....»»
AI and quantum mechanics team up to accelerate drug discovery
Drug discovery is much like working a jigsaw puzzle. The chemical compounds behind drug molecules must be shaped to fit with the proteins in our bodies to produce therapeutic effects. That requirement for a meticulous fit means the creation of new dr.....»»
SCOTUS denial ends saga of Shkreli’s infamous 5,000% drug price scheme
The Supreme Court offered no explanation for denying the petition. The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has.....»»